First Time Loading...

Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 64.31 USD -0.08%
Updated: May 10, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

243.5m
+20%
Operating Cash Flow
Growth Rates:
1 Year
+36%
3 Years
+22%
5 Years
+34%
7 Years
+65%
10 Years
+160%
303m
Investing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-
-231.8m
Financing Cash Flow
Growth Rates:
1 Year
-111%
3 Years
-499%
5 Years
-
7 Years
-
10 Years
-

Cash Flow Statement
Globus Medical Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Operating Cash Flow
Net Income
69
70
83
86
93
96
99
103
113
116
118
118
104
105
108
107
107
118
134
144
157
150
143
147
155
148
89
95
102
122
184
187
149
142
155
155
190
201
204
158
123
Depreciation & Amortization
19
20
21
21
22
22
23
23
24
25
26
28
39
44
48
51
42
39
38
38
42
44
48
51
53
55
57
60
63
66
70
70
70
70
67
68
68
70
71
91
145
Change in Deffered Taxes
(15)
(15)
(13)
(9)
(4)
(4)
(5)
(3)
6
9
13
9
(4)
(7)
(10)
(2)
8
11
14
9
1
2
1
2
4
0
2
(3)
(4)
(2)
(5)
(3)
(18)
(20)
(24)
(32)
(22)
(23)
(26)
(51)
(58)
Stock-Based Compensation
5
6
6
7
7
7
8
9
10
10
11
11
11
12
13
14
15
17
19
21
22
22
23
24
26
26
27
28
27
28
28
29
31
31
31
32
33
34
34
49
0
Other Non-Cash Items
16
17
19
19
17
19
19
20
28
28
30
31
35
37
38
40
32
35
32
34
32
32
34
32
33
33
66
71
76
77
63
59
92
92
76
77
48
49
53
92
150
Cash Taxes Paid
39
42
40
44
51
48
56
61
57
57
57
48
50
52
53
62
59
58
46
35
31
31
32
40
34
34
12
19
25
24
(8)
46
45
45
40
64
78
79
76
85
101
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
4
13
(2)
(7)
(48)
(48)
(50)
(63)
(47)
(33)
(32)
(18)
(27)
(34)
(36)
(56)
(31)
(45)
(54)
(43)
(50)
(60)
(68)
(69)
(73)
(62)
(38)
(50)
(38)
(42)
(55)
(33)
(17)
(26)
(40)
(78)
(105)
(109)
(118)
(86)
(117)
Cash from Operating Activities
94
N/A
104
+12%
108
+3%
110
+2%
79
-28%
85
+7%
85
+1%
80
-6%
124
+55%
144
+16%
155
+7%
168
+8%
148
-12%
146
-1%
148
+2%
141
-5%
159
+13%
158
-1%
165
+5%
182
+10%
182
0%
169
-7%
158
-6%
162
+3%
172
+6%
175
+2%
176
+0%
173
-2%
199
+15%
220
+11%
256
+16%
280
+9%
276
-1%
257
-7%
235
-9%
191
-19%
179
-6%
187
+5%
185
-1%
203
+10%
243
+20%
Investing Cash Flow
Capital Expenditures
(24)
(23)
(23)
(21)
(25)
(26)
(38)
(46)
(51)
(53)
(46)
(41)
(41)
(43)
(46)
(52)
(51)
(52)
(53)
(56)
(60)
(76)
(75)
(72)
(71)
(65)
(60)
(65)
(64)
(55)
(54)
(54)
(57)
(63)
(79)
(73)
(74)
(70)
(64)
(74)
(78)
Other Items
(204)
(125)
(56)
(34)
(75)
(97)
(150)
(161)
(102)
(93)
(62)
(90)
(122)
(94)
(129)
(111)
(60)
(104)
(111)
(102)
(133)
(115)
(97)
(85)
(70)
(24)
5
31
(54)
(185)
(183)
(197)
(319)
(202)
(159)
(221)
(36)
(15)
4
(4)
381
Cash from Investing Activities
(227)
N/A
(148)
+35%
(79)
+47%
(55)
+31%
(100)
-83%
(123)
-23%
(188)
-53%
(207)
-10%
(153)
+26%
(145)
+5%
(108)
+26%
(131)
-22%
(163)
-24%
(138)
+15%
(175)
-27%
(164)
+6%
(111)
+32%
(157)
-41%
(164)
-5%
(158)
+4%
(193)
-22%
(191)
+1%
(172)
+10%
(157)
+9%
(140)
+11%
(89)
+36%
(56)
+38%
(34)
+38%
(117)
-242%
(240)
-104%
(237)
+1%
(251)
-6%
(376)
-50%
(265)
+30%
(237)
+10%
(294)
-24%
(110)
+62%
(86)
+23%
(60)
+29%
(78)
-29%
303
N/A
Financing Cash Flow
Net Issuance of Common Stock
8
11
10
9
10
7
6
6
6
6
6
6
6
6
8
8
12
19
39
41
39
40
19
23
31
(47)
(70)
(49)
(32)
45
92
88
64
62
(105)
(115)
(103)
(106)
39
27
(213)
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
4
6
5
3
3
1
1
1
(1)
(1)
(2)
(3)
(5)
(11)
(10)
(10)
(10)
(11)
(11)
(11)
(7)
(7)
(6)
(6)
(7)
(2)
(2)
(6)
(6)
(7)
(9)
(6)
(9)
(10)
(10)
(10)
(7)
(7)
(8)
(8)
(19)
Cash from Financing Activities
11
N/A
17
+51%
15
-8%
12
-20%
13
+7%
8
-36%
7
-19%
8
+12%
4
-43%
5
+7%
4
-17%
3
-24%
1
-83%
(5)
N/A
(2)
+57%
(2)
+10%
2
N/A
9
+431%
28
+231%
30
+5%
33
+10%
34
+3%
12
-64%
16
+35%
24
+51%
(49)
N/A
(72)
-46%
(55)
+24%
(39)
+29%
38
N/A
83
+122%
82
-1%
54
-34%
53
-3%
(115)
N/A
(125)
-8%
(110)
+12%
(113)
-3%
31
N/A
19
-38%
(232)
N/A
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
(2)
(2)
(2)
(2)
1
2
3
1
1
(0)
(1)
0
(0)
(0)
(0)
(1)
0
1
0
0
(0)
(1)
(0)
(1)
(0)
(1)
(1)
0
2
2
Net Change in Cash
(123)
N/A
(27)
+78%
44
N/A
67
+52%
(8)
N/A
(30)
-283%
(95)
-222%
(119)
-25%
(25)
+79%
4
N/A
51
+1 253%
37
-28%
(16)
N/A
2
N/A
(30)
N/A
(24)
+21%
51
N/A
13
-75%
31
+143%
55
+79%
21
-62%
10
-52%
(2)
N/A
21
N/A
56
+166%
37
-35%
48
+30%
84
+77%
44
-48%
18
-58%
103
+468%
111
+8%
(46)
N/A
45
N/A
(118)
N/A
(228)
-93%
(43)
+81%
(12)
+72%
156
N/A
145
-7%
317
+118%
Free Cash Flow
Free Cash Flow
70
N/A
81
+16%
85
+4%
89
+5%
54
-39%
59
+8%
48
-19%
34
-28%
73
+114%
91
+25%
109
+20%
127
+16%
107
-16%
103
-3%
103
-1%
88
-14%
108
+22%
106
-2%
112
+6%
126
+13%
122
-4%
93
-24%
82
-11%
90
+9%
101
+13%
110
+9%
115
+5%
108
-7%
135
+26%
165
+22%
203
+23%
226
+12%
219
-3%
194
-11%
157
-19%
118
-25%
105
-12%
117
+12%
121
+3%
129
+7%
165
+28%

See Also

Summary
GMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
GMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GMED stock valuation using valuation multiples.
Wall Street Estimates
GMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.